AVEO Pharmaceuticals Inc – Company Profile and SWOT Analysis

AVEO Pharmaceuticals Inc – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AVEO Pharmaceuticals Inc (AVEO), is a biopharmaceutical company that focuses on the discovery, development, and commercialization of drugs for the treatment of various types of cancers. Its flagship product tivozanib is approved as a first line treatment for adult patients with renal cell carcinoma and marketed under the brand name Fotivda in European Union, Iceland and Norway. The company’s clinical product includes Ficlatuzumab, a hepatocyte growth factor inhibitory antibody, and AV-203, an anti-ErbB3 monoclonal antibody. It also has pre-clinical products in the pipeline. The company develops products through strategic partnerships with other pharmaceutical companies. AVEO is headquartered in Boston, Massachusetts, the US.

Scope

• Detailed information on AVEO Pharmaceuticals Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting AVEO Pharmaceuticals Inc in the form of a SWOT analysis

• An in-depth view of the business model of AVEO Pharmaceuticals Inc including a breakdown and examination of key business segments

• News about AVEO Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess AVEO Pharmaceuticals Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on AVEO Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Merrimack Pharmaceuticals Inc

Novartis Pharmaceuticals Corp

IFM Therapeutics LLC

Mirati Therapeutics Inc

Galaxy Biotech LLC

Roche Laboratories Inc

Novartis Pharmaceuticals Corp

IFM Therapeutics LLC

Merrimack Pharmaceuticals Inc

Onyx Pharmaceuticals Inc

Mirati Therapeutics Inc

Galaxy Biotech LLC

Daiichi Sankyo Inc

Table of Contents